Bookmarks
Welsh Neuroscience Research Tissue Bank
Datasets (2)
DECISIve Biorepository (Cardiff)
Dataset population size: 25
Health and disease, Treatments/Interventions, Measurements/Tests, Imaging types, Imaging area of the body
Collections (0)
Analysis Scripts & Software (0)
Data Uses (0)
Publications (20)
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes.
Kodosaki E, Watkins WJ, Loveless S, Kreft KL, Richards A, Anderson V, Hurler L, Robertson NP, Zelek WM, Tallantyre EC.
Relevance of Multiple Sclerosis Severity Genotype in Predicting Disease Course: A Real-World Cohort.
Kreft KL, Uzochukwu E, Loveless S, Willis M, Wynford-Thomas R, Harding KE, Holmans P, Lawton M, Tallantyre EC, Robertson NP.
CSF-resident CD4<sup>+</sup> T-cells display a distinct gene expression profile with relevance to immune surveillance and multiple sclerosis.
Hrastelj J, Andrews R, Loveless S, Morgan J, Bishop SM, Bray NJ, Williams NM, Robertson NP.
Detecting and predicting neutralization of alemtuzumab responses in MS.
Saxena G, Moore JM, Jones M, Pryce G, Ali L, Leisegang GR, Vijay V, Loveless S, Robertson NP, Schmierer K, Giovannoni G, Gnananpavan S, Baker D, Tallantyre EC, Kang AS.
Detecting and predicting neutralization of alemtuzumab responses in MS.
Saxena G, Moore JM, Jones M, Pryce G, Ali L, Leisegang GR, Vijay V, Loveless S, Robertson NP, Schmierer K, Giovannoni G, Gnananpavan S, Baker D, Tallantyre EC, Kang AS.
Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59.
Zelek WM, Watkins LM, Howell OW, Evans R, Loveless S, Robertson NP, Beenes M, Willems L, Brandwijk R, Morgan BP.